Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways

Pulmonary arterial hypertension (PAH) is a fatal condition for which there is no cure. Dimethyl Fumarate (DMF) is an FDA approved anti-oxidative and anti-inflammatory agent with a favorable safety record. The goal of this study was to assess the effectiveness of DMF as a therapy for PAH using patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Grzegorzewska, Agnieszka P., Seta, Francesca, Han, Rong, Czajka, Caitlin A., Makino, Katsunari, Stawski, Lukasz, Isenberg, Jeffrey S., Browning, Jeffrey L., Trojanowska, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288696/
https://www.ncbi.nlm.nih.gov/pubmed/28150703
http://dx.doi.org/10.1038/srep41605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288696/
https://www.ncbi.nlm.nih.gov/pubmed/28150703
http://dx.doi.org/10.1038/srep41605

Ejemplares similares